Literature DB >> 6339039

Kinetic analysis of hepatotoxicity associated with antineoplastic asparaginases.

D L Durden, A M Salazar, J A Distasio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6339039

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  12 in total

1.  Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity.

Authors:  Hien Anh Nguyen; Ying Su; Arnon Lavie
Journal:  J Biol Chem       Date:  2016-06-27       Impact factor: 5.157

2.  The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.

Authors:  Wai Kin Chan; Philip L Lorenzi; Andriy Anishkin; Preeti Purwaha; David M Rogers; Sergei Sukharev; Susan B Rempe; John N Weinstein
Journal:  Blood       Date:  2014-03-21       Impact factor: 22.113

Review 3.  Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota.

Authors:  Rachel M Golonka; Xia Xiao; Ahmed A Abokor; Bina Joe; Matam Vijay-Kumar
Journal:  J Nutr Biochem       Date:  2020-02-22       Impact factor: 6.048

4.  The eIF2 kinase GCN2 is essential for the murine immune system to adapt to amino acid deprivation by asparaginase.

Authors:  Piyawan Bunpo; Judy K Cundiff; Rachel B Reinert; Ronald C Wek; Carla J Aldrich; Tracy G Anthony
Journal:  J Nutr       Date:  2010-09-22       Impact factor: 4.798

5.  Identification and structural analysis of an L-asparaginase enzyme from guinea pig with putative tumor cell killing properties.

Authors:  Amanda M Schalk; Hien-Anh Nguyen; Coraline Rigouin; Arnon Lavie
Journal:  J Biol Chem       Date:  2014-10-15       Impact factor: 5.157

6.  GCN2 is required to increase fibroblast growth factor 21 and maintain hepatic triglyceride homeostasis during asparaginase treatment.

Authors:  Gabriel J Wilson; Brittany A Lennox; Pengxiang She; Emily T Mirek; Rana J T Al Baghdadi; Michael E Fusakio; Joseph L Dixon; Gregory C Henderson; Ronald C Wek; Tracy G Anthony
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-09       Impact factor: 4.310

7.  Severe hepatotoxicity from Escherichia coli L-asparaginase.

Authors:  R Jenkins; E Perlin
Journal:  J Natl Med Assoc       Date:  1987-07       Impact factor: 1.798

8.  Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.

Authors:  Wei-Wen Chien; Soraya Allas; Nicolas Rachinel; Pierre Sahakian; Michel Julien; Céline Le Beux; Claire-Emmanuelle Lacroix; Thierry Abribat; Gilles Salles
Journal:  Invest New Drugs       Date:  2014-05-15       Impact factor: 3.850

9.  A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo.

Authors:  Hien Anh Nguyen; Ying Su; Jenny Y Zhang; Aleksandar Antanasijevic; Michael Caffrey; Amanda M Schalk; Li Liu; Damiano Rondelli; Annie Oh; Dolores L Mahmud; Maarten C Bosland; Andre Kajdacsy-Balla; Sofie Peirs; Tim Lammens; Veerle Mondelaers; Barbara De Moerloose; Steven Goossens; Michael J Schlicht; Kasim K Kabirov; Alexander V Lyubimov; Bradley J Merrill; Yogen Saunthararajah; Pieter Van Vlierberghe; Arnon Lavie
Journal:  Cancer Res       Date:  2018-01-17       Impact factor: 12.701

10.  Is N-acetylcysteine infusion an effective treatment option in L-asparaginase associated hepatotoxicity?

Authors:  Zeynep Canan Özdemir; Ayşe Bozkurt Turhan; Makbule Eren; Özcan Bor
Journal:  Blood Res       Date:  2017-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.